Welcome to LookChem.com Sign In|Join Free
  • or
C13H11N5O is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1245652-74-7

Post Buying Request

1245652-74-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1245652-74-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1245652-74-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,6,5 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1245652-74:
(9*1)+(8*2)+(7*4)+(6*5)+(5*6)+(4*5)+(3*2)+(2*7)+(1*4)=157
157 % 10 = 7
So 1245652-74-7 is a valid CAS Registry Number.

1245652-74-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1,5-dihydroimidazo[1,2-b]pyridazin-2-yl)-N-oxobenzenecarboximidamide

1.2 Other means of identification

Product number -
Other names (Z)-N'-hydroxy-3-(imidazo[1,2-b]pyridazin-2-yl)benzimidamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1245652-74-7 SDS

1245652-74-7Relevant academic research and scientific papers

CYTOKINE INHIBITORS

-

Page/Page column 39, (2011/11/30)

Provided is a compound of Formula (I): and/or at least one pharmaceutically acceptable salt thereof. Also provided are a method of inhibiting the activity of at least one protein chosen from TNFα, IL-1β, NF-κB, IL-10 and iNOS, a method of decreasing a lev

CYTOKINE INHIBITORS

-

Page/Page column 17; 18, (2009/05/28)

A compound of Formula I: Each variable is defined in the specification. This invention relates to a method of decreasing a level of a cytokine (e.g., TNFα or interlukine such as IL-1β) in a subject with a compound of Formula I. It also relates to a method

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1245652-74-7